Supporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.
Read moreEnabled a biotech to achieve its targets by provision of expert pricing support during a company res...
Read moreReview of secondary literature and clinical trial databases to understand payer willingness to pay.
Read moreThe collaboration with the Ethical Medicines Industry Group (EMIG) will help bring greater understan...
Read moreThe only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...
Read moreOverall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...
Read moreThe objective of this research was to understand the processes and outputs from different European p...
Read moreMedicare would use a new International Pricing Index (IPI) model that considers international refere...
Read morePfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire ...
Read moreSetting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...
Read more